Loss of integrity of umbilical cord blood unit freezing bags: Description and consequences

Transfusion

Volumn 48, Issue 6, 2008, Pages 1138-1142

  Thyagarajan, Bharat ^b   Berger, Michael ^b   Sumstad, Darin ^b   McKenna Jr , David H ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

CONTAINER; CRYOPRESERVATION; DATA BASE; FREEZING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MEDICAL RECORD REVIEW; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REVIEW; THAWING; UMBILICAL CORD BLOOD;

BLOOD PRESERVATION; FETAL BLOOD; FREEZING; HUMANS; TIME FACTORS;

EID: 44849093837     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01688.x     Document Type: Review

References (13)

1. Brunstein CG, Wagner JE. Umbilical cord blood transplantation and banking. Annu Rev Med 2006 57 : 403 17.
2. Chrysler GR, McKenna DH, Schierman T, Kadidlo D, Askari. S, Miller J, Clay ME, McCullough J. Umbilical cord blood banking. In : Broxmeyer HE, editor. Cord blood: biology, immunology, banking, and clinical transplantation. Bethesda (MD) : AABB Press 2004. p. 219 57.
3. Moroff G, Eichler H, Brand A, Kekomaki R, Kurtz J, Letowska M, Pamphilon D, Read EJ, Porretti L, Lecchi L, Reems JA, Racher R, Seetharaman S, Takahashi TA. Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood. Transfusion 2006 46 : 507 15.
4. Khuu HM, Cowley H, David-Ocampo V, Carter CS, Kasten-Sportes C, Wayne AS, Solomon SR, Bishop MR, Childs RM, Read EJ. Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences. Cytotherapy 2002 4 : 539 49.
5. McKenna D, Kadidlo D, Miller J, Orchard P, Wagner J, McCullough J. The Minnesota Molecular & Cellular Therapeutics Facility: a state-of-the-art biotherapeutics engineering laboratory. Transfus Med Rev 2005 19 : 217 28.
6. McKenna D Jr, Kadidlo D, Sumstad D, McCullough J. Development and operation of a quality assurance system for deviations from standard operating procedures in a clinical cell therapy laboratory. Cytotherapy 2003 5 : 314 22.
7. Net Cord - Foundation for the Accreditation of Cellular Therapy (FACT). International standards for cord blood collection, processing, testing, banking, selection and release. 3rd ed. December 2006.
8. Cornetta K, Laughlin M, Carter S, Wall D, Weinthal J, Delaney C, Wagner J, Sweetman R, McCarthy P, Chao N. Umbilical cord blood transplantation in adults: results of the prospective cord blood transplantation (COBLT). Biol Blood Marrow Transplant 2005 11 : 149 60.
9. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, Taylor PE, Stevens CE. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 1995 92 : 10119 22.
10. Mascotti K, McCullough J, Burger SR. HPC viability measurement: trypan blue versus acridine orange and propidium iodide. Transfusion 2000 40 : 693 6.
11. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, Verfaillie CM, Wagner JE. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005 105 : 1343 7.
12. McKenna DH, Emrick E, Grunnes D, Zdeb A, Kadidlo D, McCullough J. Filtration of cord blood allows for successful engraftment [abstract Transfusion 2003 43 Suppl : 17A.
13. Draft guidance for industry: minimally manipulated, unrelated, allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution in patients with hematological malignancies. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, December 2006.